KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Mar 2025 value amounting to $207,000.

  • Ginkgo Bioworks Holdings' Gains from Investment Securities rose 122.02% to $207,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$5.5 million, marking a year-over-year decrease of 88.80%. This contributed to the annual value of -$5.7 million for FY2024, which is 10.31% down from last year.
  • As of Q1 2025, Ginkgo Bioworks Holdings' Gains from Investment Securities stood at $207,000, which was up 113.55% from -$1.5 million recorded in Q3 2024.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gains from Investment Securities registered a high of $18.5 million during Q3 2021, and its lowest value of -$107.5 million during Q4 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Gains from Investment Securities averaged around $305,500, with its median value being -$1.2 million (2024).
  • In the last 5 years, Ginkgo Bioworks Holdings' Gains from Investment Securities crashed by 997.09% in 2021 and then spiked by 142.15% in 2023.
  • Ginkgo Bioworks Holdings' Gains from Investment Securities (Quarterly) stood at -$107.5 million in 2021, then spiked by 73.15% to -$28.9 million in 2022, then skyrocketed by 92.67% to -$2.1 million in 2023, then rose by 19.20% to -$1.5 million in 2024, then spiked by 122.02% to $207,000 in 2025.
  • Its last three reported values are $207,000 in Q1 2025, -$1.5 million for Q3 2024, and -$3.2 million during Q2 2024.